Person‐specific contribution of neuropathologies to cognitive loss in old age

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of Neurology

• Publication date

  2018-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.25123PMID 29244218PMCID PMC5876116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Precision Medicine

  2019cited by this paper
• Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery

  2017cited by this paper
• Risk of incident clinical diagnosis of Alzheimer's disease–type dementia attributable to pathology‐confirmed vascular disease

  2017cited by this paper
• Neuropathologic features of TOMM40 '523 variant on late‐life cognitive decline

  2017cited by this paper
• Impact of multiple pathologies on the threshold for clinically overt dementia

  2017cited by this paper
• Precision Medicine: Clarity for the Complexity of Dementia.

  2016cited by this paper
• Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies

  2016cited by this paper
• Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study

  2016cited by this paper
• TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

  2016cited by this paper
• Higher brain BDNF gene expression is associated with slower cognitive decline in older adults

  2016cited by this paper
• Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons

  2015cited by this paper
• Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease

  2015cited by this paper
• Neural reserve, neuronal density in the locus ceruleus, and cognitive decline

  2013cited by this paper
• TDP-43 pathology, cognitive decline, and dementia in old age.

  2013cited by this paper
• Life-span cognitive activity, neuropathologic burden, and cognitive aging

  2013cited by this paper
• Much of late life cognitive decline is not due to common neurodegenerative pathologies

  2013cited by this paper
• Cognitive and social lifestyle: links with neuropathology and cognition in late life

  2013cited by this paper
• Relation of neuropathology with cognitive decline among older persons without dementia

  2013cited by this paper
• Relation of neuropathology to cognition in persons without cognitive impairment

  2012cited by this paper
• Overview and findings from the religious orders study.

  2012cited by this paper
• Overview and findings from the rush Memory and Aging Project.

  2012cited by this paper
• Hippocampal sclerosis in advanced age: clinical and pathological features.

  2011cited by this paper
• Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons

  2010cited by this paper
• The neuropathology of probable Alzheimer disease and mild cognitive impairment

  2009cited by this paper
• Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study

  2009cited by this paper
• Mixed brain pathologies account for most dementia cases in community-dwelling older persons

  2007cited by this paper
• Individual differences in rates of change in cognitive abilities of older persons.

  2002cited by this paper

• DNA methylation signature of cognitive reserve moderates CSF tau pathology in prodromal Alzheimer’s disease

  2026cites this paper
• Associations between Structural Neuroimaging Markers and Neuropathology of Alzheimer's Disease.

  2026cites this paper
• Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments.

  2026cites this paper
• A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.

  2026cites this paper
• Carboxylated graphene quantum dots inhibit Aβ42 and α-synuclein co-aggregation via competitive N-terminal targeting: An REMD study

  2026cites this paper
• Associations between structural brain alterations and dysfunction across cognitive domains in cerebral small vessel disease: A systematic review and meta-analysis

  2026cites this paper
• Neuropathologic Profiles and Associated Cognitive Trajectories in Community-Living Older Adults

  2026cites this paper
• Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline.

  2026cites this paper
• Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer’s disease by GM-CSF treatment

  2025cites this paper
• High‐caloric intake rescues early symptomatic AD‐induced hippocampal neurovascular coupling deficits

  2025cites this paper
• Neural Correlates and Adaptive Mechanisms in Vascular Cognitive Impairment: Exploration of a Structure–Function Coupling Network

  2025cites this paper
• Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization

  2025cites this paper
• Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative Review

  2025cites this paper
• Stroke caused by cerebral amyloid angiopathy: a case of difficult diagnosis

  2025cites this paper
• Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging

  2025cites this paper
• Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1-induced endoplasmic reticulum-associated degradation.

  2025cites this paper
• Depressive Symptoms and Cognitive Function in the U.S. POINTER Study.

  2025cites this paper
• Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures

  2025cites this paper
• Integrating computational approaches to unravel Alzheimer's disease and co-pathologies: a biomarker-driven approach to precision medicine

  2025influential citation
• Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline

  2025cites this paper
• Herpes Zoster Vaccination and Dementia Occurrence.

  2025cites this paper
• The association between altitude and cerebral small vessel disease burden in the Tibetan population: a cross-sectional study

  2025cites this paper
• Combining 24-Hour Continuous Monitoring of Time-Locked Heart Rate, Physical Activity and Gait in Older Adults: Preliminary Findings

  2025cites this paper
• Gene module-trait network analysis uncovers cell type specific systems and genes relevant to Alzheimer’s Disease

  2025cites this paper
• Ante-mortem cognitive trajectories associated with Aβ and tau biomarker profiles in older adults with cerebrovascular disease: a longitudinal cohort study

  2025cites this paper
• Clinical Translation of Integrated PET‐MRI for Neurodegenerative Disease

  2025cites this paper
• Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer’s disease and vascular pathology

  2025cites this paper
• Aortic Stiffness and Alzheimer’s Disease: The Medin Connection

  2025cites this paper
• Interactive effects of arterial stiffness and Alzheimer's disease risk on cognitive decline in older adults without dementia

  2025cites this paper
• MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics

  2025cites this paper
• Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers.

  2025cites this paper
• Distinct cerebrovascular pathways underlying Alzheimer’s disease-related neurodegeneration

  2025cites this paper
• Valacyclovir and Symptomatic Alzheimer Disease-No Evidence for Benefit.

  2025cites this paper
• ПРОГНОСТИЧЕСКАЯ СПОСОБНОСТЬ КОГНИТИВНОГО РЕЗЕРВА В ФОРМИРОВАНИИ СИНДРОМА МОТОРНО-КОГНИТИВНОГО РИСКА

  2025cites this paper
• Global, regional, and national burden of Alzheimer’s disease and other dementias from 1990 to 2021: findings from the Global Burden of Disease Study 2021

  2025cites this paper
• Associations of pathologic Parkinson’s disease (PD) and co-pathologies with cognitive decline and progression of parkinsonian signs in decedents with subclinical disease

  2025cites this paper
• Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy

  2025cites this paper
• The Effectiveness of Unimodal and Multimodal Warnings on Drivers’ Response Time: A Meta-Analysis

  2025cites this paper
• The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review.

  2025cites this paper
• Does white matter and vascular injury from repetitive head impacts lead to a novel pattern on T2 FLAIR MRI? A hypothesis proposal and call for research

  2025cites this paper
• A natural experiment on the effect of herpes zoster vaccination on dementia

  2025cites this paper
• Intensive Blood Pressure Lowering for Intracerebral Hemorrhage: A Systematic Review and Updated Meta-analysis of Randomized Controlled Trials

  2025cites this paper
• Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions

  2025cites this paper
• Neuropathologic correlates of distinct plasma biomarker profiles in community-living older adults.

  2025cites this paper
• Mechanisms of interventions targeting modifiable factors for dementia risk reduction

  2025cites this paper
• 2025 Alzheimer's disease facts and figures

  2025cites this paper
• Frailty and the brain: A narrative review of functional and pathological correlates.

  2025cites this paper
• The effect of shingles vaccination at different stages of the dementia disease course

  2025cites this paper
• Immune modulation to treat Alzheimer’s disease

  2025cites this paper
• ARTS is associated with vascular risk factors, MCI, dementia, and stroke

  2025cites this paper
• Plasma proteomic signatures of preclinical Alzheimer’s disease biomarkers and memory in clinically unimpaired older adults

  2025cites this paper
• Neural network mechanisms of emotional dysregulation in cerebral small vessel disease.

  2025cites this paper
• α-synuclein biomarker assays: bridging research and patient care.

  2025cites this paper
• Proteomic landscape of Alzheimer’s disease: emerging technologies, advances and insights (2021 – 2025)

  2025cites this paper
• Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage

  2025cites this paper
• Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study

  2025cites this paper
• A brain health framework with application to the study of neurodegeneration

  2025cites this paper
• Mixed Pathologies and Cognitive Outcomes in Persons Considered for Anti-Amyloid Treatment Eligibility Assessment: A Community-Based Study.

  2025cites this paper
• Clinical Implications of an Integrated Clinical and Biological Staging Scheme for Alzheimer’s Disease

  2025cites this paper
• Vascular Dementia: From Pathophysiology to Therapeutic Frontiers

  2025cites this paper
• Abnormal Amyloid-β Duration, Tau, and Neurodegeneration in Cranial Images

  2025cites this paper
• Caregivers' perspectives on lecanemab use for Alzheimer's disease: A national survey in China

  2025cites this paper
• Late-onset alzheimer’s disease, atherosclerosis, and cerebrovascular disease. A complex relationship too often neglected: a narrative review

  2025cites this paper
• Mechanisms and Impact of Cognitive Reserve in Normal Aging and Alzheimer’s Disease

  2025cites this paper
• Effect of herpes zoster vaccination on dementia occurrence: A quasi-experimental study in Australia

  2025cites this paper
• Determinants of cerebral amyloid angiopathy progression: a multicenter retrospective study

  2025cites this paper
• A Fine Balance: Anticoagulation for Non-Valvular Atrial Fibrillation After Cerebral Amyloid Angiopathy-Related Intracranial Haemorrhage.

  2025cites this paper
• Gene module-trait network analysis uncovers cell type specific systems and genes relevant to Alzheimer's Disease

  2025cites this paper
• Vulnerability to memory decline in aging revealed by a mega-analysis of structural brain change

  2025cites this paper
• Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis

  2024cites this paper
• VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders

  2024cites this paper
• [Cognitive impairment in cerebrovascular diseases].

  2024cites this paper
• 2024 Alzheimer's disease facts and figures

  2024cites this paper
• A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function

  2024cites this paper
• MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults.

  2024cites this paper
• Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology.

  2024cites this paper
• A preliminary study on the neurocognitive deficits associated with loneliness in young adults

  2024cites this paper
• Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer’s disease

  2024cites this paper
• Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis

  2024cites this paper
• Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.

  2024cites this paper
• CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex

  2024influential citation
• A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

  2024cites this paper
• Monoclonal antibodies for treating early Alzheimer disease-a commentary on recent 'positive' trials.

  2024cites this paper
• Associations between vascular health, brain stiffness and global cognitive function

  2024cites this paper
• Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks.

  2024cites this paper
• Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective

  2024cites this paper
• Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy

  2024cites this paper
• Association between pre-dementia psychiatric diagnoses and all-cause dementia is independent from polygenic dementia risks in the UK Biobank

  2024cites this paper
• A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol

  2024cites this paper
• Cerebral tau pathology in cerebral amyloid angiopathy

  2024cites this paper
• Ten Things to Remember (and Not Forget) About Vascular Cognitive Impairment

  2024cites this paper
• Validation of International Classification of Diseases, 10th Edition, Clinical Modification (ICD-10-CM) Code I68.0 for Cerebral Amyloid Angiopathy

  2024cites this paper
• Update on modifiable risk factors for Alzheimer's disease and related dementias

  2024cites this paper
• Associations of brain morphology with cortical proteins of cognitive resilience.

  2024cites this paper
• Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function

  2024cites this paper
• Chronic Traumatic Encephalopathy.

  2024cites this paper
• Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies

  2024cites this paper
• Editorial: Brain health: risk, resilience and reserve

  2024cites this paper
• Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease

  2024cites this paper
• Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change

  2024cites this paper